Register to view:

Efficient multiplexed targeted gene editing as a strategy to generate improved CHO host cell lines for biotherapeutic manufacturing applications.

Read our whitepaper in collaboration with Cergentis, where we showcase Horizon’s newly developed multiplexed gene editing strategy, and how it can be applied to engineering improved expressing cell lines for biotherapeutic manufacturing applications.

Required fields marked with *(Required)

First Name *

Last Name *

Email *

Company / Institution *

By submitting my personal data, I acknowledge that Revvity, Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy (available here).

Have an account? •